Arb. Russell et al., GRANULOCYTE-COLONY-STIMULATING FACTOR TREATMENT FOR NEONATAL NEUTROPENIA, Archives of Disease in Childhood, 72(1), 1995, pp. 53-54
In a pilot study recombinant granulocyte colony-stimulating (rhG-CSF)
was administered to 12 neutropenic preterm infants do determine if neo
natal neutropenia is secondary to decreased endogenous G-CSF productio
n, Respiratory variables were monitored because of the possible link b
etween inflammatory cells and hyaline membrane disease. All infants sh
owed increased neutrophil counts. The only possible side effect observ
ed was an exacerbation of thrombocytopenia.